OTC Antiperspirant Duration Claim Restrictions Contested By CTFA
This article was originally published in The Rose Sheet
Executive Summary
Restricting enhanced duration claims under the OTC Antiperspirant Drug Products Final Monograph violates First Amendment principles and is inconsistent with FDA regulatory precedent, according to the Cosmetic, Toiletry and Fragrance Association